Anti-convulsant effects by reduced glutathione and related aminoacids in rats treated with isoniazid.
Rats were treated with different doses of isoniazid (INH) causing convulsions. Lethal dose (DL50) and effective convulsant dose (ED50) were calculated. Reduced glutathione (GSH) and related aminoacids were administered to rats receiving INH: the latency and duration of convulsions were recorded; cerebral gamma-aminobutyric acid (GABA) concentrations were determined in rats receiving INH and an association of GSH and INH. GSH and its related aminoacids as cysteine and glycine greatly decreased the duration of INH-induced seizures, while glutamic acid did not protect against convulsions caused by INH. Furthermore, INH causes a decrease in cerebral GABA levels to about half and GSH repeated pretreatment did, however, not prevent the INH induced decline of GABA content: hence, the anticonvulsant effect of GSH can not be ascribed to the restoration of normal levels of anti-epilectically acting GABA, but can be attributed to cysteine and glycine, aminoacids linked to GSH.
D000818:Animals; D001923:Brain Chemistry; D003545:Cysteine / Q000627:therapeutic use; D004347:Drug Interactions; D005971:Glutamates / Q000627:therapeutic use; D018698:Glutamic Acid; D005978:Glutathione / Q000627:therapeutic use*; D005998:Glycine / Q000627:therapeutic use; D007538:Isoniazid / Q000633:toxicity*; D007928:Lethal Dose 50; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D005971:Glutamates; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D005978:Glutathione; D003545:Cysteine; D005998:Glycine; D007538:Isoniazid